In vitro antistaphylococcal synergistic effect of isoflavone metabolite demethyltexasin with amoxicillin and oxacillin
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60460709%3A41210%2F18%3A74459" target="_blank" >RIV/60460709:41210/18:74459 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/60460709:41340/18:74459
Výsledek na webu
<a href="http://dx.doi.org/10.1089/mdr.2017.0033" target="_blank" >http://dx.doi.org/10.1089/mdr.2017.0033</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1089/mdr.2017.0033" target="_blank" >10.1089/mdr.2017.0033</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
In vitro antistaphylococcal synergistic effect of isoflavone metabolite demethyltexasin with amoxicillin and oxacillin
Popis výsledku v původním jazyce
Staphylococcal infections are often hard to treat due to increasing resistance, especially to beta-lactams. Previous studies described the synergy between common antibiotics and isoflavonoids. However, little is yet known about the combinatory effects of antibiotics with products of human isoflavone metabolism. In this study, demethyltexasin (DT), a human body metabolite of soybean isoflavones, was evaluated for its possible antistaphylococcal combinatory effect with amoxicillin and oxacillin. For comparison, common therapeutically used combination of amoxicillin/clavulanic acid was tested. DT showed strong synergistic interactions against most of Staphylococcus aureus strains when combined with amoxicillin and oxacillin. When oxacillin was combined with DT, resistance to this antibiotic was overcome in many cases. Moreover, antibiotic/DT combinations were effective mainly against methicillin-resistant S. aureus (MRSA). However, the commonly used drug amoxicillin/clavulanic acid was effective only ag
Název v anglickém jazyce
In vitro antistaphylococcal synergistic effect of isoflavone metabolite demethyltexasin with amoxicillin and oxacillin
Popis výsledku anglicky
Staphylococcal infections are often hard to treat due to increasing resistance, especially to beta-lactams. Previous studies described the synergy between common antibiotics and isoflavonoids. However, little is yet known about the combinatory effects of antibiotics with products of human isoflavone metabolism. In this study, demethyltexasin (DT), a human body metabolite of soybean isoflavones, was evaluated for its possible antistaphylococcal combinatory effect with amoxicillin and oxacillin. For comparison, common therapeutically used combination of amoxicillin/clavulanic acid was tested. DT showed strong synergistic interactions against most of Staphylococcus aureus strains when combined with amoxicillin and oxacillin. When oxacillin was combined with DT, resistance to this antibiotic was overcome in many cases. Moreover, antibiotic/DT combinations were effective mainly against methicillin-resistant S. aureus (MRSA). However, the commonly used drug amoxicillin/clavulanic acid was effective only ag
Klasifikace
Druh
J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS
CEP obor
—
OECD FORD obor
21101 - Food and beverages
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Microbial Drug Resistance
ISSN
1076-6294
e-ISSN
1931-8448
Svazek periodika
24
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
6
Strana od-do
24-29
Kód UT WoS článku
000419819100004
EID výsledku v databázi Scopus
2-s2.0-85040612785